Guidance

Antenatal and newborn screening: laboratory quality assurance

Requirements for the quality assurance of laboratories providing antenatal and newborn screening services by the United Kingdom Accreditation Service (UKAS).

Documents

Introduction

Fetal anomaly screening: laboratory QA evidence requirements

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Infectious diseases in pregnancy screening: laboratory QA evidence requirements

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Newborn blood spot screening: laboratory QA evidence requirements

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Sickle cell and thalassaemia screening: laboratory QA evidence requirements

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The United Kingdom Accreditation Service (UKAS) quality assures laboratories providing services to the:

  • NHS fetal anomaly screening programme (FASP)
  • NHS infectious diseases in pregnancy screening (IDPS) programme
  • NHS sickle cell and thalassaemia (SCT) screening programme
  • NHS newborn blood spot (NBS) screening programme

This guidance explains the UKAS requirements and the evidence they will assess.

Published 27 July 2018